Patient characteristics
| Feature . | n (%) . |
|---|---|
| Total | 54 (100) |
| Median age, y (range) | 66 (37-79) |
| Ann Arbor stage | |
| Stage I | 32 (59) |
| Stage II | 22 (41) |
| Bilateral testicular localization | 1 (2) |
| ECOG PS | |
| 0 | 51 (94) |
| 1 | 3 (6) |
| Presence of B symptoms | 2 (4) |
| High serum LDH | 7 (13) |
| High serum β2-microglobulin (n = 46) | 8 (17) |
| Feature . | n (%) . |
|---|---|
| Total | 54 (100) |
| Median age, y (range) | 66 (37-79) |
| Ann Arbor stage | |
| Stage I | 32 (59) |
| Stage II | 22 (41) |
| Bilateral testicular localization | 1 (2) |
| ECOG PS | |
| 0 | 51 (94) |
| 1 | 3 (6) |
| Presence of B symptoms | 2 (4) |
| High serum LDH | 7 (13) |
| High serum β2-microglobulin (n = 46) | 8 (17) |
ECOG PS, Eastern Cooperative Oncology Group performance status; LDH, lactate dehydrogenase.